Timo Rager

Title: **Timo Rager: Innovator in Methylthioninium Chloride Patents**

Introduction

Timo Rager, an accomplished inventor based in Basel, Switzerland, has made significant strides in the field of pharmaceuticals through his innovative work on methylthioninium chloride. With a remarkable portfolio of four patents, Rager's contributions enhance the understanding and application of this chemical compound in various formulations.

Latest Patents

Rager's latest patents reflect his detailed approach to the refinement and application of methylthioninium chloride. One notable patent details a sophisticated process for preparing substantially pure methylthioninium chloride pentahydrate form A. This method involves phase equilibration of suspensions, crystallization, or solvent evaporation, ensuring that the water content of the solvent maintains a water activity of at least 0.4 at 25°C. Additionally, he meticulously oversees the controlled drying of this compound within specific stability ranges of humidity, pressure, and temperature.

Another patent showcases the crystalline methylthioninium chloride hydrates, describing three dihydrate forms B, C, and D, alongside a monohydrate form E. These hydrates can be synthesized under precisely regulated humidity and temperature conditions, derived from methylthioninium chloride with higher water content or through the conversion of an existing hydrate. This innovation promises to facilitate their incorporation into various pharmaceutical compositions, broadening their potential applications in medicine.

Career Highlights

Throughout his career, Timo Rager has contributed significantly to the fields of chemistry and pharmaceuticals. He has held positions in reputable companies, including Wista Laboratories Ltd. and Intervet International B.V., where he collaborated on various research projects and developed new formulations.

Collaborations

Rager's journey in innovation has been enhanced by working alongside esteemed colleagues, such as Rolf Hilfiker and Ralf Warrass. Together, they have pushed the boundaries of research and development, contributing to the body of knowledge surrounding methylthioninium chloride and its applications.

Conclusion

In summary, Timo Rager stands out as a key inventor in the pharmaceutical industry, with a focused expertise in methylthioninium chloride and a commitment to innovation. His patents not only highlight his scientific prowess but also showcase his ability to collaborate and drive advancements in this vital field. Through his work, Rager continues to make an indispensable impact on pharmaceuticals, paving the way for new therapeutic possibilities.